About: Identifai Genetics Limited provides prenatal genetic screening through the application of genome-wide sequencing and artificial intelligence in Israel, the United States, Hong Kong, China, and Australia. The company's product, Windrose, is a first-trimester non-invasive prenatal test that provides cfDNA-based fetal risk assessment for more than 280 clinically actionable genes, all from a single blood draw and without requiring a partner sample. The company was founded in 2021 and is based in Subiaco, Australia.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: A$0.44 (+7.32%)
ID1 ASX Identifai Genetics Limited
Identifai Genetics Limited share price
ID1 price activity
Last Price
$0.440
Change (24hr)
0.03 AUD (7.32%)
Volume
89.95K
Volume (4w avg)
-
Open
$0.42
Day Range
$0.41 - $0.44
Previous Close
$0.41
Last Trade
11 Nov, 4:50 am GMT+0
Delayed
11 Nov, 4:50 am GMT+0
ID1 price performance
Delayed
11 Nov, 4:50 am GMT+0
ID1 details
ID1 Market Signals